writes "The FDA recently gave clearance to Vital Art and Science Inc. (VAS) to market software which enables people with degenerative eye conditions such as macular degeneration and diabetic retinopathy to monitor their vision at home with their iPhone. The software, which is called myVisionTrack, isn't a replacement for regular visits to the doctor, but rather allows patients to keep tabs on their vision in between visits with eye care professionals.
VAS notes that retinal diseases affect approximately 40 million individuals worldwide and 13 million in the United States. While treatments have been developed to deal with degenerative eye conditions, early diagnosis is of paramount importance — which is why the software is so important."Link to Original Source